MANF stimulates autophagy and restores mitochondrial homeostasis to treat toxic proteinopathy
Y. Kim, C. Li, C. Gu, E. Tycksen, A. Puri, T. A. Pietka, J. Sivapackiam, Y. Fang, K. Kidd, S.-J. Park, B. G. Johnson, S. Kmoch, J. S. Duffield, A. J. Bleyer, M. E. Jackrel, F. Urano, s. Vijay, M. Lindahl, Y. M. Chen
Abstract
Misfolded protein aggregates may cause toxic proteinopathy, including autosomal dominant tubulointerstitial kidney disease due to uromodulin mutations (ADTKD-UMOD), one of the leading hereditary kidney diseases, and Alzheimers disease etc. There are no targeted therapies. ADTKD is also a genetic form of renal fibrosis and chronic kidney disease, which affects 500 million people worldwide. For the first time, in our newly generated mouse model recapitulating human ADTKD-UMOD carrying a leading UMOD deletion mutation, we show that autophagy/mitophagy and mitochondrial biogenesis are severely impaired, leading to cGAS- STING activation and tubular injury. Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a novel endoplasmic reticulum stress-regulated secreted protein. We provide the first study that inducible tubular overexpression of MANF after the onset of disease stimulates autophagy/mitophagy and clearance of the misfolded UMOD, and promotes mitochondrial biogenesis through p-AMPK enhancement, resulting in protection of kidney function. Conversely, genetic ablation of endogenous MANF upregulated in the mutant mouse and human tubular cells worsens autophagy suppression and kidney fibrosis. Together, we discover MANF as a novel biotherapeutic protein and elucidate previously unknown mechanisms of MANF in regulating organelle homeostasis to treat ADTKD, which may have broad therapeutic application to treat various proteinopathies.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney Disease
Chenjian Gu, Yili Fang, … Ying Maggie Chen·Journal of Clinical InvestigationPeer-reviewed·Aug 25, 2026
- Allelic and Gene Dosage Effects Involving Uromodulin Aggregates Drive Autosomal Dominant Tubulointerstitial Kidney Disease
Guglielmo Schiano, Jennifer L. Lake, … Olivier Devuyst·bioRxiv·Sep 13, 2022
- Calorie restriction leads to degradation of mutant uromodulin and ameliorates inflammation and fibrosis in UMOD-related kidney disease
Mariapia Giuditta Cratere, Benedetta Perrone, … Luca Rampoldi·Journal of the American Society of NephrologyPeer-reviewed·Feb 3, 2026
- Base Editing as a Therapeutic Strategy for Autosomal Dominant Tubulointerstitial Kidney Disease caused by Pathogenic UMOD Variants
Nora Diederich, Sarah Wendlinger, … Michael M. Kaminski·bioRxiv·Oct 16, 2026
- Myofibroblast- specific autophagy drives cyst growth in autosomal dominant polycystic kidney disease
Abeda Jamadar, Viji Remadevi, … Reena Rao·Cell Communication and SignalingPeer-reviewed·Jul 9, 2026
- Metabolic Derangement in Polycystic Kidney Disease Mouse Models Is Ameliorated by Mitochondrial-Targeted Antioxidants
N. Daneshgar, A. W. Baguley, … D.-F. Dai·bioRxiv·Sep 15, 2021